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Abstract
Background: Obese adults are prone to develop metabolic and cardiovascular diseases. Furthermore, over-weight
expectant mothers give birth to large babies who also have increased likelihood of developing metabolic and
cardiovascular diseases. Fundamental advancements to better understand the pathophysiology of obesity are
critical in the development of anti-obesity therapies not only for this but also future generations. Skeletal muscle
plays a major role in fat metabolism and much work has focused in promoting this activity in order to control the
development of obesity. Research has evaluated myostatin inhibition as a strategy to prevent the development of
obesity and concluded in some cases that it offers a protective mechanism against a high-fat diet.
Methods: Pregnant as well as virgin myostatin null mice and age matched wild type animals were raised on a high
fat diet for up to 10 weeks. The effect of the diet was tested on skeletal muscle, liver and fat. Quantitate PCR,
Western blotting, immunohistochemistry, in-vivo and ex-vivo muscle characterisation, metabonomic and lipidomic
measurements were from the four major cohorts.
Results: We hypothesised that myostatin inhibition should protect not only the mother but also its developing
foetus from the detrimental effects of a high-fat diet. Unexpectedly, we found muscle development was attenuated
in the foetus of myostatin null mice raised on a high-fat diet. We therefore re-examined the effect of the high-fat
diet on adults and found myostatin null mice were more susceptible to diet-induced obesity through a mechanism
involving impairment of inter-organ fat utilization.
Conclusions: Loss of myostatin alters fatty acid uptake and oxidation in skeletal muscle and liver. We show that
abnormally high metabolic activity of fat in myostatin null mice is decreased by a high-fat diet resulting in excessive
adipose deposition and lipotoxicity. Collectively, our genetic loss-of-function studies offer an explanation of the lean
phenotype displayed by a host of animals lacking myostatin signalling.
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Background
A chronic imbalance between dietary intake and energy
expenditure results in an accumulation of adipose tissue
and subsequent development of obesity. Given the global
prevalence of obesity and metabolic/cardiovascular disor-
ders, a better understanding of the fundamental principles
which govern diet-induced metabolic pathophysiology is
requisite to advance novel anti-obesity therapies [1].
Obesity affects not only the adult but, in pregnant
women, the development of the foetus. Irrefutable
evidence exists showing that abnormal intrauterine en-
vironment increases the susceptibility of the offspring to a
host of diseases including osteoporosis, high blood pres-
sure, insulin resistance, type 2 diabetes and even cancer
[2–8]. The lifelong effects of exposure to a high-fat diet
during pregnancy establishes a vicious cycle in that large
babies have increased probability of being obese and
therefore as adults will give birth to overweight children.
Recent evidence suggests loss of skeletal muscle meta-
bolic plasticity is central in the development of obesity
and metabolic disease. This is highlighted by numerous
studies, from mouse to man, implicating the role of skel-
etal muscle fibre type composition, size, oxidative enzyme
activity and lipid content as causal factors for predicting
or predisposing to obesity [9–15]. A reduction in the
oxidative capacity of skeletal muscle to uptake and utilize
circulating lipids along with attenuated oxidative enzym-
atic activity, increases muscle lipid content and smaller
fibre size are contributing factors in the aetiology of obes-
ity [9, 12]. Conversely, increased fatty acid oxidation in
peripheral tissues such as skeletal muscle and adipose
tissue is protective against fat accumulation in adipose tis-
sue and obesity [16]. Targeting of myostatin (Mstn) activ-
ity or signalling has emerged as a potential strategy to
combat obesity as deletion of Mstn is accompanied by a
hypermuscular phenotype. Muscle hypertrophy is accom-
panied by a change in the metabolic profile of the tissues
signified by a huge increase in the number of glycolytic fi-
bres and deficit in mitochondrial number. With regards to
adiposity, it has been shown that loss of myostatin in
leptin-deficient mice is followed by reduced accumulation
of whole-body fat content [17]. In addition, transgenic
expression of the myostatin propeptide, a molecule that
maintains myostatin in an inactive form, is proposed to be
protective against high-fat diet-induced obesity [18]. Recent
reports on Mstn knock out (Mstn−/−) mice or treatment
with myostatin antagonists (e.g. soluble activin type IIB
receptor) showed resistance to develop obesity in response
to high-fat diet (e.g. [16]). Paradoxically, a huge body of
evidence shows that an oxidative muscle profile, rather
than glycolytic protects against obesity (e.g. [19, 20]).
We hypothesised that myostatin inhibition should pro-
tect not only the mother but also its developing foetus
from the detrimental effects of a high-fat diet. Contrary to
our expectations, we found that gestational high-fat diet
had detrimental effects on skeletal muscle development by
impairing muscle fibre formation. Furthermore, we pro-
vide evidence that Mstn deletion is not beneficial in adult
mice subjected to high-fat diet. We carried out an analysis
of the three major fat handling tissues in the body to de-
velop a mechanistic explanation for our findings. Detailed
quantitative gene expression analysis revealed that the oxi-
dative profile is attenuated in muscle. Our data demon-
strates that a high-fat diet induces abnormal fatty acid
uptake and oxidation programmes in the skeletal muscle
and liver of myostatin deficient mice. Finally, we provide
evidence that a high-fat diet induced abnormal pro-
grammes of fat oxidation and energy dissipation specific-
ally in Mstn−/− mice. We suggest that a culmination of the
abnormal responses of muscle, liver and adipose tissues
results in excessive fat deposition in Mstn−/− mice.
Methods
Ethical approval
All research conducted on animals was performed under
a project license from the United Kingdom Home Office
in agreement with the Animals (Scientific Procedures)
Act 1986. All procedures were approved by the Univer-
sity of Reading Animal Care and Ethical Review Com-
mittee. Animals were humanely sacrificed via Schedule 1
killing between 0800–1300.
Animal maintenance
Healthy C57Bl/6 (WT) and Mstn−/− mice were bred and
maintained according to the NIH Guide for Care and Use
of Laboratory animals, approved by the University of Read-
ing in the biological resource unit of Reading University
whereby they were housed under standard environmental
conditions (20–22 °C, 12–12 h light–dark cycle) and
provided food and water ad libitum. All mice were of
4–5 months of age at the commencement of the study. Ex-
perimental groups were composed of 5–9 mice each. Mstn−/−
mice were a gift of Se-Jin Lee (Johns Hopkins USA).
High-fat diet protocol
Mice were caged individually and were randomly sub-
jected to a purified laboratory high-fat diet (HF diet) re-
gime or supplied with a standard laboratory mouse chow.
High-fat diet was obtained from special diet services
(SDS) with 45, 20 and 35 % of total energy intake deriving
from fat, protein and carbohydrates, respectively (diet
code: 824053). Animals were monitored daily and main-
tained under high-fat diet conditions for a maximum of
10 weeks. Upon completion of the study the heart, exten-
sor digitorum longus (EDL) plantaris, tibialis anterior,
gastrocnemius, vastus lateralis, soleus and rectus femoris
muscles as well as the liver and white adipose tissue
(WAT) from the retroperitoneal visceral fat pad from male
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and female mice were dissected and weighed. Embryos
were obtained at embryonic stage E18.5 from timed preg-
nant female mice being on a high fat diet for 9–10 weeks
at the time of tissue harvesting. Embryo hind-limbs were
embedded in Tissue Tech freezing medium (Jung) cooled
by dry ice/ethanol. Immunocytochemistry was performed
on serial cryosections as described previously [21]. No
major sex specific difference was found between the two
genotypes and most of the results presented are from male
mice as these were the bigger cohorts.
Clinical chemistry analysis of blood
Blood was collected by heart puncture in presence of
lithium heparin anticoagulant and plasma separated by
centrifugation. Up to 200 μl of plasma were analysed with
a Beckman Coulter AU680 clinical chemistry analyser.
Histological analysis and immunohistochemistry
Following dissection, muscle was immediately frozen in
liquid nitrogen-cooled isopentane and mounted in Tissue
Tech freezing medium (Jung) cooled by dry ice/ethanol.
Immunohistochemistry was performed on 10 μm cryosec-
tions which were dried for 30 min before the application
of block wash buffer (PBS with 5 % foetal calf serum (v/v),
0.05 % Triton X-100). Antibodies were diluted in wash
buffer 30 min before use. Myosin heavy chain (MHC) type
I, IIA and IIB isoforms were identified by using A4.840
IgM (1:1 dilution), A4.74 IgG (1:4 dilution) and BF-F3
IgM (1:1 dilution) supernatant monoclonal primary anti-
bodies (Developmental Studies Hybridoma Bank). An IgG
rabbit polyclonal antibody against laminin (Sigma) was used
at a concentration of 1:300. Phospho-NF-κB antibody stain-
ing (Ser536) was performed at a dilution of 1:200 (93H1
Cell Signalling UK). Macrophage marker F4/80 (1:200,
CA497R, AbD Serotec) was histologically visualised by
using the Vectastain Elite ABC kit (Vector Labs, UK).
Primary antibodies were detected using Alexa Fluor 488
goat anti-mouse IgG (Molecular Probes A11029, 1:200),
Alexa Fluor 633 goat anti-mouse IgM (Molecular Probes
A21046, 1:200) and Alexa Fluor 488 goat-anti-rabbit IgG
(Molecular Probes A11008, 1:300) secondary antibodies.
Succinate dehydrogenase (SDH) staining
Transverse EDL muscle sections were incubated for 3 min
at room temperature in a sodium phosphate buffer con-
taining 75 mM sodium succinate (Sigma), 1.1 mM nitro-
blue tetrazolium (Sigma) and 1.03 mM phenazine
methosulphate (Sigma). Samples were then fixed in 10 %
formal-calcium and cleared in xylene prior to mounting
with DPX mounting medium (Fisher). Photographic
quantification of the samples was performed on a Zeiss
Axioskop2 microscope mounted with an Axiocam HRc
camera. Axiovision Rel. 4.8 software was used to capture
the images.
Oil Red O staining
10 μm thick liver cryosections were washed in PBS and
rinsed in 60 % isopropanol. Sections from all experimental
groups were processed simultaneously with freshly pre-
pared Oil Red O working solution for 15 min. Nuclei were
counterstained with alum hematoxylin for 1 min. Sections
were mounted in aqueous mounting medium and images
were captured with a bright-field microscope.
Quantitative PCR
Tissue samples were disrupted/homogenised in Pure-
ZOL™ (Biorad) in a Tissue-lyzer (Qiagen) using stainless
steel beads (30 Hz for a total of 4 min). Total RNA was
isolated using the Aurum™ (Biorad) RNA isolation kit ac-
cording to manufacturer’s directions. For QPCR, total
RNA was deoxyribonuclease-treated on-column and
transcribed to complementary DNA using iScript™
(Biorad) following manufacturer’s protocol. QPCR was
performed with the TaqMan method (using the Roche
Universal Probe Library System) on an ABI StepOnePlus
Real-Time PCR System. Relative expression was calcu-
lated using the ΔΔCt method with normalisation to the
housekeeping gene cyclophilin-B. Specific primer/probe
sequences are available on request.
Muscle tension measurements
Dissection of the hind limb was carried out under oxygen-
ated Krebs solution (95 % O2 and 5 % CO2). Under circu-
lating oxygenated Krebs solution one end of a silk suture
was attached to the distal tendon of the EDL and the other
to a Grass Telefactor force transducer (FT03). The prox-
imal tendon remained attached to the tibial bone. The leg
was pinned to a Sylgard-coated experimental chamber.
Two silver electrodes were positioned longitudinally on
either side of the EDL. A constant voltage stimulator (S48,
Grass Telefactor) was used to directly stimulate the EDL
which was stretched to attain the optimal muscle length
to produced maximum twitch tension (Pt). Tetanic
contractions were provoked by stimulus trains of 500 ms
duration at, 10, 20, 50, 100 and 200 Hz. The maximum
tetanic tension (Po) was determined from the plateau of
the frequency-tension curve. Specific force was estimated
by normalising tetanic force to EDL muscle mass (g).
Exercise fatigue test
Following completion of a 6-week dietary intervention,
mice were acclimatised in three sessions to running on a
treadmill (10 m/min for 15 min followed by a 1 m/min
increase per minute to a maximum of 12 m/min) (Columbus
Instruments Model Exer 3/6 Treadmill, Serial S/N
120416). Exhaustion was determined by exercising the
mice at 12 m/min for 5 min, followed by 1 m/min
increases to a maximum of 20 m/min until the mouse was
unable to run.
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1H NMR spectroscopy-based metabonomic analysis
Polar metabolites were extracted from gastrocnemius
muscle using the protocol previously described by
Beckonert et al. [22]. Briefly, 40–50 mg of muscle tissue
was snap frozen in liquid nitrogen and finely ground in
300 μL of chloroform:methanol (2:1) using a tissue lyzer.
The homogenate was combined with 300 μL of water,
vortexed and spun (13,000g for 10 min) to separate the
aqueous (upper) and organic (lower) phases. A vacuum
concentrator (SpeedVac) was used to remove the water and
methanol from the aqueous phase before reconstitution in
550 μL of phosphate buffer (pH 7.4) in 100 % D2O contain-
ing 1 mM of the internal standard, 3-(trimethylsilyl)-
[2,2,3,3,-2H4]-propionic acid (TSP). For each sample, a
standard one-dimensional nuclear magnetic resonance
(NMR) spectrum was acquired with water peak suppres-
sion using a standard pulse sequence (recycle delay (RD)-
90°-t1-90°-tm-90°-acquire free induction decay (FID)). RD
was set as 2 s, the 90° pulse length was 16.98 μs, and the
mixing time (tm) was 10 ms. For each spectrum, eight
dummy scans were followed by 128 scans with an acquisi-
tion time per scan of 3.8 s and collected in 64 K data points
with a spectral width of 12.001 ppm. 1H NMR spectra were
manually corrected for phase and baseline distortions and
referenced to the TSP singlet at δ 0.0. Spectra were digitised
using an in-house MATLAB (version R2009b, the Math-
works, Inc.; Natwick, MA) script. To minimize baseline
distortions arising from imperfect water saturation, the
region containing the water resonance was excised from
the spectra. Principal components analysis (PCA) was
performed with Pareto scaling in MATLAB using scripts
provided by Korrigan Sciences Ltd, UK.
Lipid profiling
Cellular extracts from gastrocnemius were quantified on a
time-of-flight mass spectrometer (micrOTOF Q II from
Bruker Daltonics, Germany) equipped with an ESI standard
sprayer (Apollo II ESI source) according to previously pub-
lished methods [23–26]. Samples were injected using an
autosampler “ultimate WPS-3000TSL” and a multi-channel
pump “ultimate 3400 M” (Thermo Fisher, Germany). Lipids
were extracted according to [24]. Dried samples were
reconstituted in 250 μl MS-mix buffer [chloroform/
methanol/ammonium formiate (2/1/0.1 %)] and 10 μl
were infused to an Ascentis Express C8 analytical column
(Sigma-Aldrich, Germany) at a flow rate of 260 μl/min.
Chromatography was performed using a multistep gradi-
ent with buffer A (acetonitril/water 60/40) and buffer B
(2-propanol/water 97/3) containing 0.1 % ammonium for-
miate, starting with A/B 68/32 and ending A/B 3/97 after
30 min. The mass spectrometry data were processed with
Target Analysis Software (version 1.2) from Bruker
Daltonics. Sample data were processed for eight lipid sub-
classes: triglycerides, sphingomyelins, phosphatidylserines,
phosphatidylethanolamines, phosphatidylcholines, lyso-
phosphatidylcholines, cholesterolesters and ceramides,
using internal standards (TAG 19:0/19:0/19:0; PC 17:0/
17:0; LPC 17:0; SM 17:0; PE 17:0; CE 17:0; CM 17:0; SM
17:0).
Statistical analysis
Data are presented as mean ± SD. Significant differences
between two groups were performed by Student’s t test
for independent variables. Differences among groups
were analysed by two-way analysis of variance (ANOVA;
genotype x diet) followed by Bonferroni’s multiple com-
parison tests. Differences were considered statistically
significant at p < 0.05.
Results
Effect of maternal high-fat diet on embryonic muscle
development
Attenuation of myostatin signalling has been reported to
increase fatty acid metabolism. Here, we investigated the
effect of high fat on muscle development on a genetic
background that lacks myostatin (Mstn−/−); (Fig. 1a–f ).
Muscle morphology from littermate embryos was per-
formed at the developmental stage E18.5, when second-
ary myogenesis is considered to be approaching
postnatal levels. As reported previously [21], total myo-
tube number of the EDL was significantly higher in the
Mstn−/− embryos compared to the WT ones. However,
we found a significantly compromised myotube number
of 15 % in the EDL of Mstn−/− embryos from mothers
raised on a HF diet (Fig. 1a, b). Concordantly, a 30 and
12 % reduction in total myotube number was evident in
the soleus and TA muscles, respectively, of Mstn−/− em-
bryos from mothers on a HF diet in the absence of any
differences in WT embryos (Fig. 1e,f ). EDL primary and
secondary myotube cross-sectional area (CSA) was sig-
nificantly reduced by 10 % in WT embryos from
mothers kept on a HF diet. Most importantly, a signifi-
cant interaction between genotype and diet revealed a
significantly higher CSA reduction in both primary
(slow) and in particular secondary (fast) EDL myotubes
of Mstn−/− embryos by 20 and 35 %, respectively
(Fig. 1c). In addition, the number of myotubes with cen-
trally located nuclei, as an indication of myotube remod-
elling and regeneration were significantly higher in the
Mstn−/− HF mice (Fig. 1d). We examined the level of in-
flammation as a means to possibly explain the decrease
in muscle development. Histological staining for F4/80,
a macrophage marker revealed a significant increase for
both genotypes in response to high-fat diet (Fig. 2a). We
also noticed a significant increase in activated NF-κB im-
munostaining only in the Mstn−/− HF embryos (Fig. 2b).
Taken together, these novel findings suggest that mater-
nal subjection to HF diet has more severe and
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Fig. 1 (See legend on next page.)
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detrimental impact on muscle development on Mstn−/−
compared to WT embryos possibly through an induc-
tion of an inflammatory response.
Effect of high-fat diet on mouse gross anatomy
The above findings demonstrated that a maternal high-fat
diet had a detrimental effect on the foetal muscle develop-
ment programme. We also noted that pregnant as well as
virgin male and female Mstn−/− mice raised on a high-fat
diet developed precocious levels of visceral fat. The effect
of high-fat diet on percent body mass revealed a significant
increase in WT mice by 20–22 % that was evident through-
out the study (Fig. 3a). Surprisingly, Mstn−/− mice (irre-
spective of sex) subjected to a high-fat diet for 10 weeks
elicited a 37–76 % increase in body mass. Moreover, Mstn
−/− mice are known for their hypermuscular phenotype
compared to wild-type littermates and individual hind limb
muscles were heavier compared to wild-type cohorts. Curi-
ously, high-fat diet did not affect individual muscle masses
in either genotype, with the exception of TA and vastus
Fig. 2 Effect of high-fat diet on inflammatory markers of embryonic muscle. a Evidence of intramuscular macrophages stained for F4/80 and b NF-κB
immunofluorescence in embryonic muscle. Scale 100 μm, ANOVA; (*) P < 0.05 vs. WT ND; (**) P < 0.05 vs. Mstn−/− ND; (#) P < 0.05 vs. WT HF. Data are
from N = 5 embryos per group
(See figure on previous page.)
Fig. 1 Effect of high fat on embryonic muscle development. EDL muscle morphology at developmental stage E18.5 from wild type (WT) and
myostatin null (Mstn−/−) embryos from mice subjected to maternal normal (ND) or a high-fat (HF) diet. a Representative immunofluorescence
images depicting primary (slow; red) and secondary (fast; green outline) myotubes from EDL. Scale 100 μm. b Total myotube number in
EDL muscle at E18.5. c Myotube cross-sectional area and d myotubes with central nuclei per unit area. e, f Total myotube number of the
TA and soleus muscles at E18.5 from WT and Mstn−/− embryos from mothers under a ND or HF diet. ANOVA; (*) P < 0.05 vs. WT ND; (#)
P < 0.05 vs. Mstn−/− ND. Data are from N = 6–8 embryos per group
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lateralis in WT and Mstn−/−, respectively (Fig. 3b). Import-
antly, high-fat diet compromised Mstn−/− mice survival
curves by 33–45 % in male (Fig. 3c) and female mice (data
not shown). These phenotypic findings indicate that HF
diet has deleterious effects on body mass changes and life
span in the Mstn−/− mice. Histological examination of
heart did not reveal any fibrotic lesions (Fig. 3d). We fur-
thermore looked for transcript levels of key factors playing
a role in pathological heart hypertrophy and fibrosis as a
possible explanation for mortality (i.e. smooth muscle α
actin, Acta2; β myosin heavy chain, βMHC; lectin,
galactoside-binding soluble 3, Lgals3; connective tissue
growth factor, Ctgf; procollagen C-endopeptidase enhan-
cer, Pcolce; and sarcoplasmic reticulum Ca2+ ATPase,
Serca2a). Acta2 mRNA were elevated in Mstn−/− mice
compared to WT and were further increased in Mstn−/−
mice in response to HF diet (Fig. 3e). Mstn−/− ND mice
showed significantly higher mRNA levels for βMHC and
Lgals3 compared to WT ND and high-fat diet led to in-
creased levels for both genes only in WT HF mice. No
changes were found for Ctgf, Pcolce and Serca2a.
Effect of high-fat diet on blood lipids, liver function
markers and cellular damage markers
Plasma lipids were profiled with a Beckman Coulter
AU680 clinical chemistry analyser. High-fat diet led
to a significant increase of total-HDL and LDL-
cholesterol and glycerol in both WT and Mstn−/−
Fig. 3 Effect of high-fat diet on body mass, skeletal muscle masses, animal survival curve and cardiac muscle. a Percent changes of body mass in
wild type (WT) and myostatin null (Mstn−/−) mice subjected to either a normal (ND) or a high-fat (HF) diet for 10 weeks. ANOVA; (*) P < 0.05 vs. WT ND;
(#) P < 0.05 vs. WT HF; (**) P < 0.005 vs. Mstn−/− ND. b Effect of high-fat (HF) diet on EDL, soleus, plantaris, tibialis anterior (TA), gastrocnemius, rectus
femoris and vastus lateralis muscle masses. c Animal survival curve in wild type (WT) and myostatin null (Mstn−/−) mice subjected to either a normal
(ND) or a high-fat (HF) diet. ANOVA; (*) P < 0.05 vs. WT normal diet (ND); (#) P < 0.05 vs. Mstn−/− ND. A 33 and 45 % reduction of animal survival in Mstn
−/− HF diet cohort was observed at the 8-week and 10-week time point, respectively. d Trichrome staining on the heart muscle. Scale 100 μm. e mRNA
levels of key markers involved in cardiac hypertrophy and fibrosis. ANOVA; (*) P < 0.05 vs. WT ND, (#) P < 0.05 vs. WT HF; (**) P < 0.005 vs. Mstn−/− ND ;
N = 5 male mice per group
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mice of either sex (Fig. 4). Triglyceride levels were
twice the levels in Mstn−/− mice on a normal diet
compared to similarly fed WT animals. In addition,
triglycerides and free fatty acids were significantly in-
creased only in the Mstn−/− HF mice. Liver function
markers were unaffected in WT HF mice, while Mstn−/−
HF mice showed an increase for bilirubin and aspartate
aminotransferase as well as a decrease for alanine amino-
transferase, respectively (Fig. 4). Interestingly, markers of
cellular damage (i.e. lactate dehydrogenase, amylase and
creatine kinase) were significantly increased only in the
Mstn−/− HF mice (Fig. 4) and Additional file 1: Table S1.
Effect of high-fat diet on muscle metabolic properties
Fat catabolism takes place in the mitochondria. Given
the impaired mitochondrial contents that characterise
the muscles of Mstn−/− mice [27], we next focused our
analysis on mitochondrial respiration in skeletal muscle
Fig. 4 Effect of high-fat diet on blood lipids, liver function markers and markers of cellular damage. ANOVA; (*) P < 0.05 vs. WT ND; (**) P < 0.05 vs.
Mstn−/− ND; (#) P < 0.05 vs. WT HF. Data are from N = 5 male mice per group
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Fig. 5 Effect of high-fat diet on EDL muscle mitochondrial activity, fibre type and contractile properties. a EDL succinate dehydrogenase (SDH) activity
in wild type (WT) and myostatin null (Mstn−/−) mice subjected to a normal (ND) or high-fat (HF) diet for 4 and 10 weeks. Representative histochemical
staining for SDH. Scale 100 μm. N = 6 mice per group. b Quantification of SDH-positive (SDH+) fibres among groups. ANOVA; (*) P < 0.05 vs. WT ND; (#)
P < 0.05 vs. WT HF. c Fibre type changes on EDL from wild type (WT) and myostatin null (Mstn−/−) mice subjected to a normal (ND) or high-fat (HF) diet
for 4 and 10 weeks. ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF. N = 6 mice per group. d EDL muscle contractile properties in wild type (WT)
and myostatin null (Mstn−/−) mice subjected to a normal (ND) or high-fat (HF) diet. ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF. N = 6 mice
per group. Exercise fatigue test of from wild type (WT) and myostatin null (Mstn−/−) mice subjected to a normal (ND) or high-fat (HF) diet for 6 weeks.
ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. Mstn−/− ND; (**) P < 0.05 vs. WT HF. N = 5 male mice per group
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from WT and Mstn−/− mice in response to high-fat diet.
Mitochondrial activity estimated via SDH histological
staining showed a significant increase in SDH positive fi-
bres in WT mice after both 4 and 10 weeks of HF diet
by 5 % (Fig. 5a, b). As expected, Mstn−/− mice had fewer
SDH positive fibres compared to WT cohorts but sub-
jection to high-fat diet did not affect SDH levels in Mstn
−/− mice. This finding may be taken as functional com-
pensation in the WT mice to metabolise the excess of
fat supplied by nutrition or alternatively as failure to ap-
propriately augment mitochondrial activity in response
to high-fat diet by the Mstn−/− mice. We next analysed
muscle fibre composition of EDL muscle in order to de-
cipher the role of skeletal muscle morphology on total
body metabolism and the development of obesity.
In line, with the SDH findings, we observed a fibre
type shift from glycolytic IIB to more oxidative types
(i.e. IIX and IIA) after 4 and 10 weeks of HF diet in
the wild-type mice. In contrast, no significant changes
were found in EDL muscle fibre types for Mstn−/−
mice subjected to HF diet (Fig. 5c). Taken together,
the changes in SDH and MHC isoforms found in WT
mice potentially indicate functional metabolic alter-
ations that favour fat buffering and utilization in a
system with excess fat content. However, this mech-
anism is not activated robustly in Mstn−/− animals.
Effect of high-fat diet on muscle contractile properties
We next determined the effect of HF diet on EDL
muscle contractile properties. As previously reported
by us and others, EDL tetanic and specific force were
significantly lower in Mstn−/− EDL muscles compared
to WT mice subjected to normal diet [28, 29]. Twitch
tension revealed a significant interaction between diet
and genotype originating mainly in a 30 % reduction
for WT mice in response to HF diet (Fig. 5d). We
also observed a significant reduction in tetanic ten-
sion for WT mice on HF diet, which exceeded the
known low levels found in Mstn−/− mice (Fig. 5d). By
normalising tetanic force to wet muscle mass, we
found a sharp reduction in specific tension for WT
mice reaching the known attenuated levels of Mstn−/−
mice (Fig. 5d). Overall, HF diet did not have any im-
pact on the contractile properties of Mstn−/− mice.
These findings indicate that despite the metabolic re-
modelling of EDL muscle for WT mice, HF has detri-
mental effects on muscle contractile properties. In
addition, the already compromised contractile proper-
ties of Mstn−/− EDL muscle were not further affected
by HF diet. When animals were challenged by an ex-
ercise fatigue protocol, we noticed an attenuated exer-
cise tolerance for both genotypes under HF diet
which was more pronounced in the Mstn−/− mice
(Fig. 5d).
Effect of high-fat diet on the expression of genes
controlling metabolic activity in skeletal muscle
We next determined the gene expression patterns of
Mstn and key metabolic regulators in EDL. HF diet did
not affect EDL Mstn mRNA levels in the WT mice and
as expected Mstn transcript was not detectable in the
Mstn−/− mice (Fig. 6a). We determined the transcript
levels of key genes involved in fatty acid uptake (i.e.
Cd36, Fatp1, Cpt1b, Slc25a20 and Cpt2), mitochondrial
fatty acid oxidation (i.e. Acadl and Acadm) as well as
glucose metabolism (i.e. Pdk4, Glut1 and Glut 4;
Fig. 6b–d). High-fat diet resulted in a significant induc-
tion of gene products that regulate fatty acid uptake (i.e.
Fatp1, Cpt1b and Slc25a20) in EDL muscle in both WT
and Mstn−/− mice (Fig. 6b). However, a significant inter-
action was evident between diet and genotype originat-
ing in a more robust induction of mRNA levels in the
WT mice compared to Mstn−/− with regard to fatty acid
uptake genes Cd36 (i.e. 1.3 in WT vs. 0.3-fold change in
Mstn−/−) and Cpt2 (i.e. 0.9-fold in WT vs. 0.2-fold
change in Mstn−/−) as well as the fatty acid oxidation
genes Acadl (i.e. 1.6-fold in WT vs. 0.5-fold change in
Mstn−/−) and Acadm (i.e. 1.1-fold in WT vs. 0.4-fold
change in Mstn−/−; Fig. 6b, c). A significant main effect
of genotype was apparent on mRNA levels of genes that
regulate glucose metabolism (i.e. Pdk4, Glut1 and
Glut4), due to the predominant glycolytic muscle pheno-
type of the Mstn−/− mice. Moreover, HF diet did not
affect expression of glucose metabolism genes with the
exception of a significant increase on Glut1 (constitutive
glucose transporter in the fasting state [30]) levels only
in the WT cohort (Fig. 6d). We also found that wild-type
mice subjected to HF diet show a 4-fold upregulation of
ucp1 in the EDL muscle, which is blunted in the Mstn−/−
HF diet mice (Fig. 6c). A similar profile of gene expression
was discovered when we examined transcripts in the so-
leus muscle (Additional file 2: Figure S1). Collectively,
these data show a sub-optimal transcriptional adaptation
of muscle HF in the absence of myostatin.
Effect of high-fat diet on the expression of genes control-
ling metabolic activity in liver
As the EDL of Mstn−/− mice showed a blunted response
to HF, we next determined the gene expression patterns
of key metabolic regulators in the liver, another major
site regulating adiposity. We measured mRNA levels of
genes that regulate fatty acid uptake (i.e. Cd36, Cpt1b,
Slc25a20 and Cpt2), fatty acid oxidation (i.e. Acadl and
Acadm), and glucose metabolism (i.e. Pdk4, Glut1 and
Glut4) as well as transcriptional regulators of energy me-
tabolism from the family nuclear receptors (i.e. Ppara,
Ppard, Pgc1a and Pgc1b). We found that HF diet in-
duced genes involved in fatty acid uptake and oxidation
only in the WT cohort (Fig. 7a–d). Conversely, gene
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expression level changes were blunted in the liver of
Mstn−/− HF mice for all genes regulating fatty acid up-
take, except Acadl and Acadm (involved in fatty acid
oxidation). With regard to genes that control glucose
metabolism, HF diet increased mRNA levels of glucose
transporters Glut1 and Glut4 and decreased Pdk4 levels
in the WT mice, all changes suggesting an increased
metabolic response and glucose utilization (Fig. 7c). HF
diet significantly reduced Pdk4, did not affect Glut1 and
increased Glut4 mRNA levels in the Mstn−/− mice
(Fig. 7c). With the exception of Glut1, the changes on
mRNA levels of Pdk4 and Glut4 also denote increased
glucose metabolism and transport within the liver. We
also examined the expression of Ppara, a master regula-
tor of lipid metabolism in the liver and adipose tissue
[31]. Ppara was upregulated in WT mice in response to
Fig. 6 Effect of high-fat diet on EDL muscle gene expression. EDL gene expression levels of a Myostatin, b key factors regulating fatty acid uptake (i.e.
Cd36, Fatp1, Cpt1b, Slc25a20 and Cpt2), c fatty acid oxidation (i.e. Acadl and Acadm) as well as Uucp1 and d glucose metabolism (i.e. Pdk4, Glut1 and Glut
4). ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF; (**) P < 0.05 vs. Mstn−/− ND. N = 6 male mice per group
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a high-fat diet. However, the gene was induced less ro-
bustly at significant levels by high fat in gene Mstn−/−
mice (Fig. 7d). Taken together, this data indicates that
the transcriptional regulation of fat metabolism by the
liver in Mstn−/− mice is compromised. This finding sug-
gests that Mstn−/− mice do not handle the excess of diet-
ary fats like WT mice. We therefore conducted a
profiling of tissue fat content for fat droplet deposition
in the liver (Fig. 7e). Oil Red O staining revealed a pro-
nounced fat accumulation in the liver of WT mice main-
tained on a HF diet, a profile that differed greatly from
the control condition. Significantly and in contrast to
WT mice, we found that there was no fat deposition in
the livers of Mstn−/− mice raised on a high-fat diet. In-
deed, there was no change in Oil Red profiles between
Mstn−/− mice raised on HF compared to normal diet.
Effect of high-fat diet on gene expression patterns of
white fat
A qualitative evaluation of abdominal fat depots re-
vealed a large increase in visceral fat contents in the
Mstn−/− mice in response to HF diet (Fig. 8a). This
finding was unexpected given previous evidence sug-
gesting that Mstn−/− mice are protected against diet-
induced obesity (e.g. [16, 17]). We sought to deter-
mine the gene expression patterns of the same key
regulators of fatty acid uptake, oxidation, glucose me-
tabolism and transcriptional regulators in white adi-
pose tissue of WT and Mstn−/− mice subjected to HF
diet with a view of developing an understanding of
mechanisms underpinning the excessive fat deposits
in the Mstn−/− mice fed on high-fat diet (Fig. 8b–d).
A significant interaction between genotype and diet was
evident for Cpt1b, Slc25a20, Cpt2, Fatp1 and Fabp3
originating in either a significant upregulation for the WT
cohort or a blunted response for the Mstn−/− mice
(Fig. 8b). Cd36 gene expression was induced in a similar
manner for both genotypes. Similarly, fatty acid oxidation
gene expression (i.e. Acadl and Acadm mRNA levels) was
significantly upregulated in the WT mice and totally
blunted in the Mstn−/− mice (Fig. 8c). Taken together,
these data suggest that fatty acid metabolism within the
adipose tissue of the Mstn−/− mice is transcriptionally
compromised at least in two different levels; fatty acid up-
take as well as fatty acid oxidation. On the contrary, WT
mice gene expression changes suggest an increased cap-
acity for both cellular uptake and use of fatty acids. Again,
as for the liver, Ppara was more robustly activated in WT
compared to Mstn−/− in response to high fat (Fig. 8d).
Examination of the expression of Ucp1 in the fat revealed
a striking finding. WT fat from mice raised on normal or
high-fat diets expressed very little Ucp1. In contrast, Mstn
−/− mice expressed elevated levels of Ucp1 in the normal
state which was dramatically decreased following the
introduction of a high-fat diet. Similar profiles were ob-
tained for Ucp1 protein levels (Fig. 8c, e). These results
suggest that the normal white fat of the Mstn−/− mice has
a high activity of Ucp1 and thereby resembles brown fat.
The browning of fat has been shown to be mediated by
signalling initiated by Fndc5/irisin [32]. Recent studies
have found that white fat expresses this protein and regu-
lates its metabolic properties in an autocrine fashion [33].
We found that the expression of Fndc5/irisin decreased
by 4-fold in WT mice following the introduction of a
high-fat diet. In contrast, its levels dropped by 13-fold in
Mstn−/− mice following the same intervention (Fig. 8d).
These results show that the fatty acid uptake and fatty acid
oxidation programmes are robustly induced by high fat in
adipose tissues of WT mice by high fat but this response
is minimal in Mstn−/− mice. Furthermore, we show that
levels of Ucp1 which would act to metabolise fat are dra-
matically decreased in the adipose tissue of Mstn−/− mice
in response to high fat possibly due to a decrease in the
expression of FNdc5/irisin. Since the irisin-Ucp1 pathway
that regulates the development of brown adipose tissue
(BAT) was perturbed in Mstn−/− HF mice, we measured
transcript levels of key genes that promote BAT (i.e.
Cidea, PR domain zinc finger protein 16; Prdm16; proton
assistant amino acid transporter-2, Pat2; Fig. 9a). There
was a significant increase of all three genes in WT HF
mice, while Mstn−/− HF mice showed a blunted response.
Similarly, we measured the mRNA levels of adipophilin
(Plin2) and perilipin (Plin5), two genes that regulate fat
cell metabolism and lipid storage in white adipose tissue.
Plin2 is known to have an adipogenic role, while Plin5 can
be both adipogenic or lipolytic [34]. There was a signifi-
cant increase in mRNA for both genes in WT but not in
Mstn−/− in response to HF (Fig. 9b). Plin2 mRNA levels in
the liver were not affected by diet, but there was a signifi-
cant main effect of the genotype with Mstn−/− HF mice
having lower levels vs. WT cohorts. At last, we found a
significant increase in Plin4 and Lipe in the liver of WT
HF mice without any change for the Mstn−/− HF mice
(Fig. 9c).
(See figure on previous page.)
Fig. 7 Effect of high-fat diet on liver gene expression and liver fat deposition. Liver gene expression levels of a key factors regulating fatty acid
uptake (i.e. Cd36, Cpt1b, Slc25a20 and Cpt2), b fatty acid oxidation (i.e. Acadl and Acadm), c glucose metabolism (i.e. Pdk4, Glut1 and Glut 4) as well
as d transcriptional regulators (i.e. Ppara, Ppard, Pgc1a and Pgc1b). ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF; (**) P < 0.05 vs. Mstn−/−
ND. N = 6 mice per group. e Representative histological images of liver fat contents by Oil Red O staining from wild type (WT) and myostatin null
(Mstn−/−) male mice subjected to a normal (ND) or high-fat (HF) diet for 10 weeks. Scale 100 μm
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Metabonomic analysis of skeletal muscle
Metabolic profiles were obtained from the hydrophilic
extracts of the gastrocnemius muscle by 1H NMR spec-
troscopy. Score plot from the pair-wise PCA model
comparing WT and Mstn−/− control muscles revealed
differences between the two genotypic groups driven by
higher creatine/phosphocreatine in the muscles of WT
mice and lower lactate compared to Mstn−/− muscle
(Fig. 10a–e). Clear differences were observed in the
metabolic profiles of the muscles when feeding WT mice
a HF diet (Fig. 10a). From the corresponding loadings
plot, the HF diet can be seen to increase muscular
Fig. 9 Gene expression of brown adipose tissue (BAT) markers and fat cell metabolism in a, b white adipose tissue (WAT) and c in the liver.
ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF; (**) P < 0.05 vs. Mstn−/− ND. N = 5 male mice per group
(See figure on previous page.)
Fig. 8 Effect of high-fat diet on body fat contents and on white adipose tissue gene expression. a Visceral fat deposition in WT and Mstn−/− mice
subjected to either a ND or a HF diet. Note the excessive fat contents in the Mstn−/− HF cohort. White adipose tissue (WAT) gene expression
levels of b key factors regulating fatty acid uptake (i.e. Cd36, Cpt1b, Slc25a20, Cpt2, Fatp1 and Fabp3), c fatty acid oxidation (i.e. Acadl and Acadm)
and Ucp1. d Fatty acid transcriptional regulator Ppara and regulator of Upc1-Fndc5/irisin. ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF; (**)
P < 0.05 vs. Mstn−/− ND. N = 6 mice per group. e Representative immunoblot for ucp1 protein. N = 3 male mice per group
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anserine and decrease lactate in the WT mice (Fig. 10d).
Anserine is a histidine-related compound with estab-
lished antioxidants properties in skeletal muscle and
brain of several species that is believed to inhibit lipid
oxidation by means of free radical scavenging or metal
chelation [35, 36]. In contrast, the HF diet did not in-
duce any robust metabolic perturbations in the muscles
of Mstn−/− mice (Fig. 10b). Comparing the metabolic
phenotypes of WT and Mstn−/− muscle fed, a HF diet re-
vealed the Mstn−/− muscle to contain higher amounts of
lactate while the WT muscle contained greater amounts
of creatine/phosphocreatine and anserine (Fig. 10c). We
complemented these studies by performing an extensive
analysis in the lipid content in muscle. Triglyceride con-
tents in cellular extracts from gastrocnemius showed a
significant increase for both genotypes in response to
HF diet, which however was more pronounced in KO
HF mice (Fig. 10f ). No major effects were observed for
other lipid subclasses, except a significant decrease for
phosphatidylethanolamines in HF mice for both geno-
types (Additional file 3: Figure S2).
Discussion
Previous evidence indicates that genetic loss of myos-
tatin increases lean body mass, prevents adipose tis-
sue accumulation and attenuates the obese and
diabetic phenotypes in mice [17]. Since then, several
groups have investigated whether the myostatin sig-
nalling inhibition can be an effective strategy against
obesity and insulin resistance. It was proposed that
inhibition of the myostatin pathway in mice results in
resistance to develop high-fat diet-induced and gen-
etic obesity, suggesting a potential role for myostatin
inhibition in the treatment of obesity and diabetes
(e.g. [37]). Intriguingly, our datasets provide compre-
hensive evidence against the protective role of myos-
tatin deletion with regard to the development of
obesity in the adult as well as perturbing the foetal
muscle development programme following exposure
to a high-fat diet. In particular, HF diet had devastat-
ing effects on both animal survival curves and tran-
scriptional profiles of muscle, liver and fat tissue.
These findings are in agreement with Guo et al. who
reported increased fat mass and adipocyte size in
Mstn−/− mice held on a HF diet for 10 weeks [38].
However, on closer inspection of data rather than the
headline statements there may be congruence between
our finding and those of others who claim a protect-
ive effect as even Guo et al., state that Mstn−/− ‘were
not completely resistant to the effects of diet-induced
obesity’ [38]. Certainly, our results are more pro-
nounced than those previously reported and given
that we have used the same lines as others, this sug-
gests that environmental factors significantly influence
the phenotype of mice with extremely physiological
properties (hypermuscular, hyperglycolytic and fatigue
prone). One influence could be the gut microbiota.
This has been shown to vary across animal studies
and even within wild-type mouse cohorts [39–41].
This is of particular relevance since the gut micro-
biome has been shown to regulate the activity of key
molecules that control muscle lipid oxidation [42]
and is able to protect against diet-induced obesity.
We suggest that the microbiome of our mice differ
from those in other research institutes. These varia-
tions have little effect on wild-type mice when chal-
lenged to a high-fat diet. However, Mstn−/− mice
which already display a genotype specific metabolic
profile (including circulating lipids) respond to a
high-fat diet in a detrimental manner and develop
obesity. This line of thought could possibly be
exploited to develop anti-obesity interventions by
comparing the microbiome of a cohort of mice that
are prone to fat deposition to others which are pro-
tective. Such a study, although very attractive is tech-
nically and logistically demanding and beyond the
scope of this study.
Our data would argue against the beneficial role of
myostatin deficiency in the control of obesity. However,
antagonism of myostatin signalling towards the same
end warrants further investigation, since epigenetic in-
terventions, as opposed to germ line deletion, have been
shown to increase muscle mass without major decreases
in oxidation capacity [43]. However, there is a growing
body of evidence that post-natal myostatin inhibition-
mediated muscle growth has detrimental outcomes espe-
cially when the tissue is exposed to environmental stress.
Two particular studies exemplify this fact. The study of
Relizani showed that blockade of activin receptor IIB
signalling induced muscle fatigability and metabolic my-
opathy [44]. Secondly, and of particular relevance to our
study, is the finding of Wang et al. [45] who reported
that post-natal inhibition of myostatin signalling in a
type 1 diabetic model, rather than attenuating actually
increased the severity of hyperglycemia. Indeed, the lat-
ter study demonstrated that myostatin inhibition led to
elevated serum levels of corticosterone. Significantly, this
class of glucocorticoid is known to promote obesity. We
suggest that more studies in animal models are required
before rolling out anti-myostatin treatments for either
therapeutic or preventative regimes in humans.
We show that HF impacted on foetal muscle develop-
ment more severely on the Mstn−/− compared to wild-
type mice, a conclusion reached by either comparing the
number of muscles affected, decreases in fibre number as
well as size and the higher number of immature fibres
(gauged through central nucleation). HF has been shown
to influence pre-natal muscle development by regulating
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the expression of key markers of myogenic commitment
including MyoD, through local upregulation of NF-кB in-
flammatory signalling pathways [46]. We suggest that at-
tenuated fat handling in maternal tissues in Mstn−/− leads
to increased lipid transfer across the placenta which is
documented to cause widespread inflammation in obese
conditions including the activation of NF-кB.
Skeletal muscle with high oxidative capacity and high
prevalence of oxidative myofibres as demonstrated in
various experimental models (e.g. transgenic mice overex-
pressing Ppard and ERRgamma) are associated with
improved metabolic profiles and resistance to obesity
[47, 48]. Thus, the predominant glycolytic, non-oxidative
muscle phenotype found in Mstn−/− (i.e. IIB fibres) would
support the notion that they are susceptible in developing
obesity. To gain an overview about the metabolic and con-
tractile properties of the skeletal muscle under a HF diet,
we assessed muscle fibre type, mitochondrial activity by
means of SDH staining and contractile properties by
measuring force. Our findings show that HF induced a
shift towards more oxidative fibres (IIB to IIA) in EDL of
the WT cohort. These changes were in accordance with
more SDH positive fibres in EDL muscle. On the contrary,
HF diet did not affect MHC and SDH in Mstn−/− EDL
muscle. Muscle oxidative properties are known to be im-
paired and mitochondrial DNA decreased in Mstn−/− fast
muscles [49] which could explain the blunted response of
the Mstn−/− EDL muscle.
Metabolic gene expression changes in response to HF diet
Our molecular analysis suggests that WT mice exhibit a
more robust transcriptional response in muscle to a
high-fat diet compared to Mstn−/−. This finding suggests
that Mstn−/− mice can adapt their transcriptional ma-
chinery to uptake and utilize fatty acids in the skeletal
muscle but do so sub-optimally. WT muscle responds to
high fat not only by taking up lipids but also activating
programmes promoting its disposal through the produc-
tion of ATP evidenced by the induction of Ucp1. Despite
these responses, the function of muscle in terms of ten-
sion production is compromised. Paradoxically, the
blunted response of Mstn−/− high fat protects it from
fat-uptake induced muscle tension loss.
However, our study shows that other important fat
handling tissues also malfunction in Mstn−/− mice in
response to high fat. Remarkably, whereas all the genes
examined that control fatty acid uptake were upregulated
by high fat in the livers of WT mice, none were affected
by the intervention in Mstn−/−. It should be noted that
Ppara, a master regulator was upregulated in both geno-
types by high fat but again more robustly in WT liver.
Most telling was our histological examination of the livers
for fat storage in response to a change in diet. There was a
huge increase in Oil Red O staining, an indicator of fat de-
position, in the livers of WT mice but no change at all in
the analogous tissues from Mstn−/− mice. Hence, we sug-
gest that the buffering capacity afforded by the liver in
WT mice is negligible if not absent in Mstn−/−.
White adipose tissue serves as the primary lipid stor-
age facility in the body. Furthermore, adipose tissue is
able to adapt to increased available fat by increasing its
rate of lipid oxidation thereby safeguarding against obes-
ity [50]. However, high-fat diets have been demonstrated
to not only leads to the hypertrophy of this tissue but
also its dysfunction signified by the activation of stress
pathways and the activation of macrophages leading to
tissue remodelling [51]. Our results highlight two mech-
anisms which could act in concert to bring about the ex-
treme levels of visceral adipose tissue found in the Mstn
−/− mice that were fed a high-fat diet. We report that
markers of fatty acid oxidation (Acad1 and Acadm) were
upregulated in adipose tissue by the high-fat diet in WT
mice but not changed in Mstn−/− mice. Secondly, we
show that the abnormally high levels of Ucp1 and pro-
tein which would act to decrease fat content, found in
normal diet Mstn−/− tissue was dramatically reduced by
the high-fat regime. Our finding that adipose tissue from
Mstn−/− mice displays elevated levels of Ucp1 could ex-
plain the lack of fat in a number of species lacking the
activity of this gene including mice, dogs, and humans
[52–54]. Furthermore, they shed light onto the mecha-
nisms by which Mstn−/− displays elevated Ucp1 expres-
sion through finding that the tissue expresses about 4-
fold higher levels of Fndc5/Irisin, a mediator of fat
browning. High-fat diet reduces the levels of this gene in
Mstn−/− to the levels found in WT tissue. Interestingly,
we found that levels of Fndc5 were unaffected in either
background by diet in fast and slow muscle as well as
liver (data not shown) implying that other myokines act
to mediate the effect on adipose tissue reported here.
(See figure on previous page.)
Fig. 10 Metabonomic analysis of skeletal muscle. Pair-wise comparisons of the metabolic profiles obtained from gastrocnemius muscle from wild type
(WT) and myostatin null (Mstn−/−) mice under normal and high-fat diet (ND and HF, respectively). Principal components analysis (PCA) scores plots
comparing a WT ND vs. WT HF (PC1 vs. PC2); b WT HF vs. Mstn−/− HF (PC1 vs. PC3); c Mstn−/− ND vs. Mstn−/− HF (PC1 vs. PC3); (% variance explained
in the parenthesis). Colour loadings plots shown for d PC2 of the model comparing WT ND vs. WT HF and e PC3 of the model comparing WT HF vs.
Mstn−/− HF. Product of PC loadings with standard deviation of the entire data set coloured by the square of the PC loading. f Triglyceride levels in
cellular extracts of the gastrocnemius muscle given as fractions. ANOVA; (*) P < 0.05 vs. WT ND; (#) P < 0.05 vs. WT HF; (**) P < 0.05 vs. Mstn−/− ND. N = 4
male mice per group
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We suggest that the excessive visceral adipose that
develops in Mstn−/− induced by a high-fat diet is due to
a blunting of the fatty acid oxidation programme and a
decrease in mechanisms that dissipate oxidative energy
as heat.
Muscular metabolic response to HF diet
WT muscle undergoes metabolic adaptation in response
to the HF diet, which is consistent with the oxidative
phenotype of the muscle fibres that the WT animals
possess. Reductions in tissue lactate in these mice reflect
the preferential consumption of fatty acids as a primary
substrate to support their energy requirements. Lactate is
a product of anaerobic glycolysis, a process that is attenu-
ated in the muscles of WT mice following a HF diet. In
contrast, the Mstn−/− mice appear unable to adapt to this
dietary modulation. Indeed, comparing muscles from
Mstn−/− and WT mice fed a HF diet found the Mstn−/−
muscle to contain higher amounts of lactate and lower
amounts of creatine/phosphocreatine. This biochemical
variation results from the glycolytic phenotype of the
Mstn−/− muscle and the lack of oxidative capacity [55, 56].
Following a HF diet, anserine was observed to increase in
the muscle of WT mice. Anserine is commonly found in
the skeletal muscle of many vertebrates and has been
shown to act as H+ buffer in glycolytic tissues [57], be an
efficient metal-chelating agent [58] and activate myosin
ATPase [59]. Anserine, and other histidine-related dipep-
tides, also possess antioxidant properties and protect
against oxidative stress [36, 59]. Elevated anserine in the
WT muscle may form part of a strategy to scavenge lipid
oxidation by-products as reactive carbonyl species, formed
during fatty acid oxidation, can react with DNA bases and
lead to the formation of advanced lipoxidation products
that can cause cellular damage and lead to oxidative
stress-related diseases [60]. In agreement, there is evi-
dence suggesting that histidine-containing dipeptides can
quench reactive species originating from lipid oxidation in
skeletal muscle [61].
From the metabolic profiles, the Mstn−/− mice appear
incapable of handling the metabolic consequences of a
HF diet. Skeletal muscle of Mstn−/− mice does respond
transcriptionally to a high-fat diet but the expression of
genes associated especially with fatty acid oxidation are
severely attenuated which would offer a plausible
explanation for the build-up of triglycerides that we
detected through our lipidomic analysis.
Conclusions
In the present study, we challenged the Mstn−/− mouse by
subjecting it to a high-fat diet regime for several weeks in
an attempt to shed more light into the mechanistic
insights of obesity development in this hypermuscular
mouse model. Intriguingly, our data comprehensively
demonstrates that myostatin deletion is not beneficial
against the development of obesity and fat tissue accumu-
lation. We show that skeletal muscle and liver of Mstn−/−
mice are unable to adapt in a normal manner to utilise
excessive dietary fat. We suggest that this leads to accu-
mulation in the adipose stores. However, at this site, the
programme of fat oxidation is blunted leading to compart-
mental hypertrophy. Furthermore, we show that white
adipose tissue of Mstn−/− mice have brown fat characteris-
tics exemplified by the elevated levels of Fndc5/Irisin and
Ucp1. However, the levels of both these factors which
would act to reduce adipose levels are greatly reduced by
a high-fat diet. These results offer a novel explanation for
the lean phenotype displayed by a range of animals lacking
myostatin.
Finally, this work has evolutionary implications and of-
fers an additional reason, to previous reports demon-
strating hyperfatigability, as to why nature does not
select a hypertrophic condition.
Additional files
Additional file 1: Table S1. Blood parameters. Values from minimum of
six male mice. (DOCX 13 kb)
Additional file 2: Figure S1. Effect of high fat diet on Soleus muscle
gene expression. Soleus gene expression levels of (A) Myostatin, (B) key
factors regulating fatty acid uptake (Cpt1b, and Cpt2), (C) fatty acid
oxidation (i.e. Acadl and Acadm) and (D) glucose metabolism (i.e. Glut1
and Glut 4). ANOVA; (*) P<0.05 vs. WT ND; (#) P<0.05 vs. WT HF; (**)
P<0.05 vs. Mstn-/- ND. N=6 male mice per group.
Additional file 3: Figure S2. Effect of high fat diet on Gastrocnemius
lipid content. All values are fraction of total lipid content. ANOVA; (*)
P<0.05 vs. WT ND; WT HF; (**) P<0.05 vs. Mstn-/- ND. N=6 male mice per
group.
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